⌘K
Loading ticker…
As of 2026-08-24, Lantern Pharma Inc. Common Stock (LTRN) has a 3-month relative strength percentile of 10 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 37. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 9.4%, relative volume 1.59×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
LTRN is held by 3 ETFs as of Apr 2026. Top owner: DFSU at 0.00% weight, $4K notional. Top 3 carry $6K.
Held by 7 ETFs · $578K across latest filings · largest weight 0.20% (MEDX).
Top 3 by value, from SEC N-PORT-P filings dated Apr 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| DFSU | 0.00% | $4K | — |
| DFACDimensional U.S. Core Equity 2 ETF | 0.00% | $2K | — |
| DCOR | 0.00% | $8 | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | LTRN Jan avg: 14.35% median: 1.81% win: 50% σ: 27.31% n: 4 2022-04-12 → 2026-07-31 | LTRN Feb avg: -6.38% median: -9.64% win: 25% σ: 14.47% n: 4 2022-04-12 → 2026-07-31 | LTRN Mar avg: 2.28% median: -11.20% win: 25% σ: 57.03% n: 4 2022-04-12 → 2026-07-31 | LTRN Apr avg: -0.59% median: -0.56% win: 40% σ: 33.03% n: 5 2022-04-12 → 2026-07-31 | LTRN May avg: 16.85% median: 6.33% win: 60% σ: 34.68% n: 5 2022-04-12 → 2026-07-31 | LTRN Jun avg: 0.71% median: 3.61% win: 60% σ: 14.78% n: 5 2022-04-12 → 2026-07-31 | LTRN Jul avg: -6.91% median: -10.16% win: 20% σ: 28.68% n: 5 2022-04-12 → 2026-07-31 | LTRN Aug avg: -3.08% median: -2.50% win: 25% σ: 3.69% n: 4 2022-04-12 → 2026-07-31 (current) | LTRN Sep avg: -8.94% median: -8.91% win: 25% σ: 12.78% n: 4 2022-04-12 → 2026-07-31 | LTRN Oct avg: -15.57% median: -13.60% win: 0% σ: 8.33% n: 4 2022-04-12 → 2026-07-31 | LTRN Nov avg: 17.90% median: 11.03% win: 75% σ: 30.04% n: 4 2022-04-12 → 2026-07-31 | LTRN Dec avg: 3.06% median: 3.87% win: 50% σ: 15.61% n: 4 2022-04-12 → 2026-07-31 |